Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Sanofi signs new oncology research deals

December 20, 2010 Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs

Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
News

Sanofi and Merck Serono to collaborate in oncology

December 17, 2010 Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis

Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …
News

Pharma careers options – management in China

December 17, 2010 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
Feature

New hepatitis C drug offers cure for more patients

December 17, 2010 Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
News

Merck KGaA appoints new head of pharma

December 17, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Appointment

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
News

Patient deaths halt Lilly cancer trial

December 15, 2010 Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
News

Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D

December 15, 2010 Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development

Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Appointment

Sanofi extends Genzyme share deal deadline

December 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions

Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
News
Amgen HQ

Amgen and Actelion meet to “talk takeover”

December 13, 2010 Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
News

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010 Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
News

China to ‘overtake US in innovation by 2020’

December 13, 2010 Research and Development, Sales and Marketing AstraZeneca, China, India, innovation

China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
News

Bristol-Myers Squibb appoints new UK general manager

December 13, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, appointment, recruitment, sales and marketing

Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …
News

Pfizer: WikiLeaks claims “preposterous”

December 10, 2010 Research and Development Nigeria, Pfizer, Trovan, WikiLeaks, ceftriaxone, clinical trial safety, industry reputation

Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …
News

Hormone therapy drugs ‘increase heart disease risk’

December 10, 2010 Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen

Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025